Herpes zoster neuralgia
Conditions
Interventions
Experimental group:Give vitamin D2 supplement,10000IU/w(5000IU/capsule),the treatment period is 12 weeks.
Control group:Do not give vitamin D2 supplement,only oral placebo two capsules per week with the same shape and smell,the treatment period is 12 weeks.
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.In accordance with the diagnostic criteria of herpes zoster neuralgia; 2.Age>=50 years; 3.BMI:18-28; 4.The course of herpes zoster =4.
Exclusion criteria
Exclusion criteria: 1.Patients currently taking vitamin D supplements; 2.Patients with those diseases including Hyperphosphatemia with renal rickets or Hypervitamin D syndrome or patients with hypothyroidism or hyperthyroidism; 3.Patients with primary or secondary hyperparathyroidism; 4.Renal insufficiency or Hypercalcemia; 5.Other neuropathic pain, such as diabetic peripheral neuropathy; 6.Pregnant or lactating female patients; 7.Participating in or participating in other clinical trials within the previous 12 weeks; 8.Patients with extremely poor blood sugar control:HbA1c>9%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric rating scale score for pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brief pain assessment scale;The 7-item generalized anxiety disorder scale (GAD-7);Patient health questionnaire-9;Pittsburgh Sleep Quality Index;Whether it develops into PHN;25(OH)D level;Rescue analgesic use;Numeric rating scale score for pain; | — |
Countries
China
Contacts
Public ContactShen Wen
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed